首页|基于属性层次模型和加权TOPSIS法的注射用紫杉醇(白蛋白结合型)药物利用评价标准建立与应用

基于属性层次模型和加权TOPSIS法的注射用紫杉醇(白蛋白结合型)药物利用评价标准建立与应用

扫码查看
目的 建立注射用紫杉醇(白蛋白结合型)的药物利用评价(DUE)标准。方法 以注射用紫杉醇(白蛋白结合型)药品说明书为基础,结合相关的诊疗指南、文献及医院实际使用情况制订DUE标准,并从医院信息系统(HIS)随机选取 2021 年 1 月至 2022 年 12 月采用注射用紫杉醇(白蛋白结合型)治疗的病历 326 份,采用属性层次模型(AHM)和加权逼近理想解排序(TOPSIS)法评价用药合理性。结果 适应证、用法用量、静脉滴注前药物配制、联合用药、输液器、化学药物治疗顺序、过敏及呕吐反应预处理、治疗周期内血常规监测、不良反应监测与处理、疗效评价、基线血常规监测、体力状况评估的AHM分析结果符合一致性检验,权重值分别为 17。875%,14。286%,13。095%,11。508%,0。397%,0。794%,13。889%,15。873%,6。349%,4。762%,0。794%,0。397%;326 份病历的相对接近程度系数(Ci)介于 47。70%~100。00%,≥80。00%(合理)的有 173 份(53。07%),60。00%~<80。00%(基本合理)的有 135 份(41。41%),<60。00%(不合理)的有 18 份(5。52%);不合理用药主要集中在适应证、治疗期间血常规监测、用法用量、过敏及呕吐反应预处理等方面。结论 该院注射用紫杉醇(白蛋白结合型)的临床使用总体较合理。所建立的方法操作方便,结果真实、直观,可用于指导注射用紫杉醇(白蛋白结合型)的临床合理使用。
Establishment and Application of Criteria for Paclitaxel for Injection(Albumin Bound)Based on Attribute Hierarchy Model and Weighted TOPSIS Method
Objective To establish the drug utilization evaluation(DUE)criteria for Paclitaxel for Injection(Albumin Bound).Methods Based on the instructions of Paclitaxel for Injection(Albumin Bound),the DUE criteria were formulated according to relevant diagnostic and treatment guidelines,literature and actual use in hospital.A total of 326 medical records with Paclitaxel for Injection(Albumin Bound)as treatment drug from January 2021 to December 2022 were randomly selected from the Hospital Information System(HIS),and the rationality of drug use was evaluated by the attribute hierarchy model(AHM)and the weighted technique for order preference by similarity to ideal solution(TOPSIS)method.Results The AHM analyses of indications,dosage and usage,drug preparation before intravenous drip,combined drug use,infusion apparatus,chemotherapy sequence,pretreatment of allergic and vomiting reactions,routine blood monitoring during treatment,monitoring and treatment of adverse reactions,efficacy evaluation,routine blood monitoring at baseline and assessment of physical status were all in line with the consistency test,with weights of 17.875%,14.286%,13.095%,11.508%,0.397%,0.794%,13.889%,15.873%,6.349%,4.762%,0.794%,0.397%,respectively.The similarity coefficient(Ci)of 326 medical records was in the range of 47.70%to 100.00%.The medical records with Ci≥80.00%(rational)accounted for 53.07%(173 ones),60.00%≤Ci<80.00%(basically rational)accounted for 41.41%(135 ones),Ci<60.00%(irrational)accounted for 5.52%(18 ones).The irrational drug use mainly were indications,routine blood monitoring during the treatment,dosage and usage,pretreatment of allergic and vomiting reactions and so on.Conclusion The clinical use of Paclitaxel for Injection(Albumin Bound)in this hospital is generally rational.The established method is easy,real and intuitive,which can be used to guide the clinical rational use of Paclitaxel for Injection(Albumin Bound).

attribute hierarchy modelweighted TOPSIS methodPaclitaxel for Injection(Albumin Bound)drug utilization evaluation

张婷、高尔云、王坚、段晓玲

展开 >

安徽省马鞍山市人民医院,安徽 马鞍山 243000

属性层次模型 加权逼近理想解排序法 注射用紫杉醇(白蛋白结合型) 药物利用评价

安徽省教育厅科研项目

KJ2021A1424

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(8)
  • 23